Chapter 7 Flashcards

1
Q

Three main categories of genetic predisposition to cancer

A
  • autosomal dominant cancer syndromes (e.g. FAP)
  • defective DNA repair syndromes (e.g. HNPCC)
  • familial cancers without known genetic basis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Features of autosomal dominant cancer syndromes

A
  • usually a point mutation in a gene for a tumor suppressor, with the second allele silenced in somatic cells
  • usually have a “marker phenotype”, such as multiple benign tumors in the affected tissue (as in FAP)
  • usually develop cancers in specific organs
  • incomplete penetrance and variable expressivity can be seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How might inflammation promote the development of cancer

A
  • chronic inflammatory states may result in immune dysregulation
  • tissue injury may result in excessive proliferation of cells
  • chronic inflammation may increase the pool of stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Basic principles of the molecular basis of cancer

A
  • non-lethal genetic damage is essential (and may be triggered by environmental agents, viruses, or inherited in the germ line)
  • tumors are formed by the clonal expansion of a single precursor
  • the principal targets of genetic damage causing cancer are 1) proto-oncogenes; 2) tumor suppressors; 3) genes involved in apoptosis and 4)DNA repair genes
  • carcinogenesis is multistep, involving several mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Proto-oncogenes

A
  • may be growth factors, transcription factors, cell cycle components, signal transducers, etc
  • mutation of them results in their constitutive activity, causing self-sufficiency in growth signals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Three main mechanisms for tumor suppression by p53

A
  • temporary cell cycle arrest (quiescence)
  • permanent cell cycle arrest (senescence)
  • programmed cell death (apoptosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does p53 cause cell cycle arrest?

A

-transcription of p21, which inhibits cyclin-CDK complexes and phosphorylation of RB, preventing the cell cycle from progressing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Two ways beta-catenin is involved in cancer progression

A
  • loss of binding by APC frees it to translocate to the nucleus, interact with TCF and cause transcription of genes such as cyclinD1 and c-myc
  • mutation resulting in loss of the E-cadherin/Beta-catenin contact inhibition allows beta-catenin again to travel to the nucleus to stimulate proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ways cancers can evade apoptosis

A
  • p53 mutations preventing apoptosis

- Bcl2 upregulation preventing apoptosis (e.g. when translocated beside the IgH gene that is transcriptionally active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does angiogenesis get promoted in tumors?

A
  • hypoxia induces HIF which activates transcription of angiogenic factors such as VEGF
  • loss of p53 can provide a more permissive environment for angiogenesis as normally p53 stimulates expression of anti-angiogenic molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Possible DNA repair mechanisms contributing to cancer development

A
  • mismatch repair genes
  • nucleotide excision repair
  • recombination repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are most carcinogens metabolised?

A
  • p450 dependent mono-oxygenases

- therefore, susceptibility to carcinogens is dependent on inherited polymorphisms in genes encoding these enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do chemical carcinogens cause cancer?

A

-mutagenesis, usually of tumor suppressors and oncogenes like p53 and RAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is UVB carcinogenic

A

-forms pyrimidine dimers in DNA that should be repaired by the nucleotide excision repair pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HTLV-1

A
  • the only RNA retrovirus known to cause cancer in humans
  • infects T cells and is transmitted sexually and by blood products
  • causes expansion of a nonmalignant polyclonal population through stimulatory effects of its Tax gene
  • thse proliferating cells are at risk for mutation, eventually resulting in a monoclonal population emerging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DNA viruses that can cause cancer

A
  • HPV
  • EBV
  • HHV8
  • HBV
  • Merkel cell polyoma virus
17
Q

HPV

A
  • low risk types that cause warts do not integrate into the host genome, while high risk ones doe
  • E7 binds RB and displaces it from E2F, and also inactivates p21 and p27; promotes proliferation
  • E6 binds and degrades p53 and BAX, reducing apoptosis, and activates telomerase
18
Q

Tumors associated with EBV

A

-Burkitt, BCL in immunocompromised/AIDS patients, some Hodgkin’s lymphoma, nasopharyngeal and gastric carcinomas and some NK/T cell lymphomaes

19
Q

How do HCV and HBV cause cancer

A
  • immunologically mediated chronic inflammation with hepatocyte death leading to regeneration and genomic damage
  • i.e. the immune response to the virus induces the damage
20
Q

Immune surveillance

A
  • the immune system when functioning normally is responsible for surveilling the body for emerging malignant cells and destroying them
  • products of mutated proto-oncogenes, etc are produced in the cell and can be expressed on MHC 1 and recognized by CD8 cells
  • some tumors overexpress normal antigens (e.g. tyrosinase in melanoma) and T cells may mount a response to these
  • CTLs recognize proteins produced by oncogenic viruses
  • cell-mediated immunity is the dominant antitumor mechanism in vivo
21
Q

Molecular diagnostics related to cancer

A
  • diagnosis (e.g. clonality, specific translocations, etc) by PCR
  • prognosis (e.g. m-myc amplification in neuroblastoma, Her2)
  • detection of minimal residual disease (e.g. amplification of BCR-ABL in CML
  • diagnosis of hereditary predisposition (e.g. BRCA)
22
Q

How do tumor cells evade the immune system?

A
  • selective outgrowth of antigen negative variants by eliminating highly immunogenic subclones
  • reduced expression of Mhc molecules
  • lack of costimulation (may both prevent the response but also induce anergy)
  • release of immunosuppressive products
  • antigen masking by glycocalyx molecules such as silicon acid
  • apoptosis of cytotoxic t cells